A Heart Valve That Grows Up With The Patient Wins FDA Approval

Key TakeawaysThe U.S. Food and Drug Administration approved the first replacement heart valve that can be widened as a child growsThe Autus valve may spare children with congenital pulmonary valve disease from repeated open-heart surgeriesDoctors widen the valve with a balloon instead of surgery, though experience with expanding it remains limited.FRIDAY, Oct. 2, 2026 (HealthDay News) — Children born with certain heart defects may face fewer open-heart surgeries, thanks to a new replacement valve that grows with them.The U.S. Food and Drug Administration (FDA) on Thursday approved the Autus Size-Adjustable Valve, the first heart valve built to be expanded after it's implanted. It's for children with congenital pulmonary valve disease, which affects the valve that controls blood flow from the heart to the lungs.Congenital heart defects are among the most common U.S. birth defects, affecting about 1 in 100 babies. Two pulmonary valve conditions, stenosis (a narrowed valve) and atresia (a valve that didn't form properly), together occur in around 4,200 U.S. babies each year, according to the U.S. Centers for Disease Control and Prevention (CDC).Repairs can improve blood flow, but some children still have a leaky valve. Over time, that leak can strain and enlarge the right side of the heart, and a replacement valve becomes necessary.Current replacement valves come in fixed sizes, so children can outgrow them. Valves are also typically made from animal tissue, which can wear out. That often means another surgery."For children born with congenital heart disease, valve replacement timing has always been a difficult decision — wait too long and you risk harm to the child, but intervene too early and they may need multiple open-heart surgeries as they grow," Dr. Michelle Tarver, director of the FDA's Center for Devices and Radiological Health, said in a news release.The Autus valve can be implanted at about 13 millimeters wide, small enough for a toddler or preschooler. As the child grows, doctors can widen it up to 22 millimeters, close to adult size, using a small balloon threaded through a blood vessel.The valve's inner flaps, called leaflets, are made of a synthetic material rather than animal tissue. It's the first FDA-approved valve of any kind to use this material.The approval is based on a study of 62 children at 12 U.S. hospitals. All procedures succeeded, with no deaths, strokes or blood clots needing treatment. Two children who began outgrowing their valves had them widened without surgery. Experience with expansion is still limited, and longer-term studies are underway, the FDA noted."Children with congenital pulmonary valve disease have long needed prosthetic valves that can account for growth over time," said Dr. Emile Bacha, surgeon-in-chief at NewYork-Presbyterian/Columbia University Irving Medical Center in New York City, who was an investigator in the trial.The valve went through premarket approval, the FDA's toughest review process, used for the highest-risk devices. It previously received Breakthrough Device designation, which speeds review of promising devices for serious conditions. More informationVisit the Boston Children’s Hospital website to learn more about how the new heart valve was developed.SOURCES: U.S. Food and Drug Administration, Oct. 1, 2026; Edwards Lifesciences, news release, Oct. 1, 2026 .What This Means For YouIf a child in your life is born with pulmonary valve problems and needs a replacement, this new device may mean fewer heart surgeries over time. .Sign up for our weekly HealthDay newsletter

A Heart Valve That Grows Up With The Patient Wins FDA Approval

Related Stories

Two Charged In Scheme To Sell Counterfeit Ozempic — How You Can Spot Fake Meds

The Drugs And Devices Have Been On The Market For Years. But FDA-Ordered Studies Still Aren't Done.

FDA Authorizes First Wearable To Track Both Ketones And Blood Sugar

FDA Clears First Robot That Draws Blood On Its Own